Trial Management STREAM

31. Going From Good To Great As A TMF Champion 12/8/2023

    Gain insight into regulatory nuances, best practices for documentation management, and strategies for fostering a culture of compliance within the team.

32. Ensuring Completeness, Accuracy, And Consistency From Source To Archive 8/22/2023

    Discover how proficient TMF handling can proactively address potential pitfalls, fostering a state of preparedness for regulatory evaluations.

33. End-To-End Clinical Data Flow 6/24/2024

    Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.

34. Secrets To A Collaborative Model To Improve TMF Management 10/30/2023

    Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.

35. CTIS Master Series 1: Are You Ready For CTIS? 3/22/2022

    In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.

36. Illuminating IHC: From Biomarker To Clinical Trial Assay 5/2/2025

    Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.

37. Exploring The Principles Integral To Rare Disease Drug Development 6/12/2024

    This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.

38. Take A Look Inside The Pharmacodynamic Toolbox 1/30/2023

    This session explores the flexible selection of pharmacodynamic measures to enhance the pharmacology, safety, and efficacy evaluation of a CNS-active drug in early clinical trials.

39. The New Era Of Project Optimus: Implications For Oncology Development Strategy 9/10/2025

    In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.

40. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.